ANTONIO - New drug combinations are helping women with early breast
cancer. Using two drugs that more precisely target tumors doubled the
number of women whose cancer disappeared compared with those who had
only one of the drugs, doctors reported Friday.
It was the first test of Herceptin and Tykerb together for early-stage
disease. They aim at a protein called HER-2 that is overproduced in
about one-fourth of all breast cancers. Herceptin blocks the protein on
the cell's surface; Tykerb does it inside the cell... Read More